Literature DB >> 31654352

Capsule Commentary on Stryczek et. al., De-implementing Inhaled Corticosteroids to Improve Care and Safety in COPD Treatment: Primary Care Providers' Perspectives.

Isomi M Miake-Lye1.   

Abstract

Mesh：

Substances：

Year:  2020        PMID： 31654352      PMCID： PMC6957616          DOI： 10.1007/s11606-019-05395-8

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN： 0884-8734            Impact factor:   5.128


× No keyword cloud information.
  5 in total

1.  Decreased continuity in a residency clinic: a consequence of open access scheduling.

Authors:  Kathy Phan; Steven R Brown
Journal:  Fam Med       Date:  2009-01       Impact factor: 1.756

2.  Burnout and satisfaction with work-life balance among US physicians relative to the general US population.

Authors:  Tait D Shanafelt; Sonja Boone; Litjen Tan; Lotte N Dyrbye; Wayne Sotile; Daniel Satele; Colin P West; Jeff Sloan; Michael R Oreskovich
Journal:  Arch Intern Med       Date:  2012-10-08

3.  De-implementing Inhaled Corticosteroids to Improve Care and Safety in COPD Treatment: Primary Care Providers' Perspectives.

Authors:  Krysttel Stryczek; Colby Lea; Chris Gillespie; George Sayre; Scott Wanner; Seppo T Rinne; Renda Soylemez Wiener; Laura Feemster; Edmunds Udris; David H Au; Christian D Helfrich
Journal:  J Gen Intern Med       Date:  2019-08-08       Impact factor: 5.128

4.  Impact of formal continuing medical education: do conferences, workshops, rounds, and other traditional continuing education activities change physician behavior or health care outcomes?

Authors:  D Davis; M A O'Brien; N Freemantle; F M Wolf; P Mazmanian; A Taylor-Vaisey
Journal:  JAMA       Date:  1999-09-01       Impact factor: 56.272

5.  Impact of Advanced Access on access, workload, and continuity: controlled before-and-after and simulated-patient study.

Authors:  Chris Salisbury; Alan A Montgomery; Lucy Simons; Fiona Sampson; Sarah Edwards; Helen Baxter; Stephen Goodall; Helen Smith; Val Lattimer; D Mark Pickin
Journal:  Br J Gen Pract       Date:  2007-08       Impact factor: 5.386
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.